Kazia Therapeutics Ltd ADR Cash Flow Reinvestment Rate

Latest as of September 2021: 1.00x

Kazia Therapeutics Ltd ADR cash flow reinvestment rate. Kazia Therapeutics Ltd ADR (KZIA) has a Cash Flow Reinvestment Rate of 1.00x as of September 2021, reinvesting $3.16 Million (capex $1.58 Million plus investments $-1.58 Million) from operating cash flow of $3.16 Million. Explore Kazia Therapeutics Ltd ADR (KZIA) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

1.00x

(Capex + Investments) / Operating CF

Total Reinvested

$3.16 Million

Capex + Investments

Operating Cash Flow

$3.16 Million

USD

Capital Expenditures

$1.58 Million

USD

Kazia Therapeutics Ltd ADR Cash Flow Reinvestment Rate by Year (None–None)

Kazia Therapeutics Ltd ADR cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Kazia Therapeutics Ltd ADR. For the full cash flow conversion analysis, see Kazia Therapeutics Ltd ADR (KZIA) cash flow conversion.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow